Monitoring CD49d receptor occupancy: A method to optimize and personalize natalizumab therapy in multiple sclerosis patients.
about
Monitoring CD49d receptor occupancy: A method to optimize and personalize natalizumab therapy in multiple sclerosis patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Monitoring CD49d receptor occu ...... n multiple sclerosis patients.
@en
Monitoring CD49d receptor occu ...... n multiple sclerosis patients.
@nl
type
label
Monitoring CD49d receptor occu ...... n multiple sclerosis patients.
@en
Monitoring CD49d receptor occu ...... n multiple sclerosis patients.
@nl
prefLabel
Monitoring CD49d receptor occu ...... n multiple sclerosis patients.
@en
Monitoring CD49d receptor occu ...... n multiple sclerosis patients.
@nl
P2093
P2860
P50
P356
P1476
Monitoring CD49d Receptor Occu ...... in Multiple Sclerosis Patients
@en
P2093
Aina Teniente-Serra
Antonio Cano-Orgaz
Bibiana Quirant-Sánchez
Marco A Fernández-Sanmartín
Maria José Mansilla
Silvia Presas-Rodríguez
P2860
P304
P356
10.1002/CYTO.B.21527
P577
2017-04-17T00:00:00Z